CPLP Capital Product Partners LP

16.80

0.00 (0.00%)

Pre Market

Last Updated: 12:00:06

Delayed by 15 minutes

Name	Symbol	Market	Type
Capital Product Partners LP	NASDAQ:CPLP	NASDAQ	Trust

	Price Change	% Change	Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.00	0.00%	16.80	16.12	17.49				0	12:00:06

Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)

05/03/2018 9:36pm

Edgar (US Regulatory)

LOGO

March 5, 2018

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Re:

Notice of disclosure filed in Annual Report on Form 20-F pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended

Ladies and Gentlemen:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Capital Product Partners L.P. has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2017, which was filed with the U.S. Securities and Exchange Commission on March 5, 2018.

Respectfully submitted,


CAPITAL PRODUCT PARTNERS L.P.

By:		Capital GP L.L.C., its general partner

By:		/s/ Gerasimos (Jerry) Kalogiratos
Name:		Gerasimos (Jerry) Kalogiratos
Title:		Chief Executive Officer of Capital GP L.L.C.